Chapter 20. Diagnosis and Management of Renovascular Disease

  1. Donald A. Molony MD2,3 and
  2. Jonathan C. Craig MD, PhD4,5
  1. Jörg Radermacher MD

Published Online: 4 MAR 2009

DOI: 10.1002/9781444303391.ch20

Evidence-Based Nephrology

Evidence-Based Nephrology

How to Cite

Radermacher, J. (2008) Diagnosis and Management of Renovascular Disease, in Evidence-Based Nephrology (eds D. A. Molony and J. C. Craig), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444303391.ch20

Editor Information

  1. 2

    Division of Renal Disease and Hypertension, University of Texas, USA

  2. 3

    Houston Medical School, Houston, Texas, USA

  3. 4

    School of Public Health, University of Sydney, Australia

  4. 5

    Department of Nephrology, The Children's Hospital at Westmead, Sydney, Australia

Author Information

  1. Department of Nephrology, Klinikum Minden, 32427, Minden, Germany

Publication History

  1. Published Online: 4 MAR 2009
  2. Published Print: 5 DEC 2008

ISBN Information

Print ISBN: 9781405139755

Online ISBN: 9781444303391



  • renovascular disease;
  • screening methods for renal artery stenosis;
  • quantification of stenosis and estimation of functional relevance;
  • exclusion of renoparenchymatous disease;
  • cholesterol embolism and radiocontrast toxicity


This chapter contains sections titled:

  • Introduction

  • Pathophysiology of renal artery stenosis

  • Patients who should be screened for renal artery stenosis

  • Screening methods for renal artery stenosis

  • Quantification of stenosis and estimation of functional relevance

  • Exclusion of renoparenchymatous disease

  • Correction of renal artery stenosis versus drug treatment

  • Improving short- and long-term results of correction of renal artery stenosis

  • Cholesterol embolism and radiocontrast toxicity

  • Conclusions

  • References